The combination of PRIMA-1Met and SAS further causes a redox imbalance and increases oxidative stress in both wt and mutant p53 CLL cells, resulting in a synergistic effect on cell survival. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.